Legend Biotech annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Legend Biotech Depreciation & Amortization Growth & History (LEGN)
Legend Biotech's depreciation and amortization was $9.4M for fiscal 2025.
View full Legend Biotech company overviewLegend Biotech annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.4M | −$3.2M | −25.58% |
| 2024 | 2024-12-31 | $12.6M | $3,000 | +0.02% |
| 2023 | 2023-12-31 | $12.6M | $2.5M | +24.13% |
| 2022 | 2022-12-31 | $10.2M | $2.0M | +24.99% |
| 2021 | 2021-12-31 | $8.1M | $1.9M | +30.56% |
| 2020 | 2020-12-31 | $6.2M | $2.2M | +55.81% |
| 2019 | 2019-12-31 | $4.0M | — | — |
Legend Biotech quarterly depreciation and amortization
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.7M | $5.9M | +101.72% |
| Q1 2026 | 2026-03-31 | $15.6M | $10.5M | +205.88% |
| Q4 2025 | 2025-12-31 | $12.0M | — | — |
| Q3 2025 | 2025-09-30 | $6.0M | $3.7M | +153.34% |
| Q2 2025 | 2025-06-30 | $5.8M | $3.0M | +108.63% |
| Q1 2025 | 2025-03-31 | $5.1M | $2.3M | +82.40% |
| Q3 2024 | 2024-09-30 | $2.4M | −$294,000 | −10.99% |
| Q2 2024 | 2024-06-30 | $2.8M | — | — |
| Q1 2024 | 2024-03-31 | $2.8M | — | — |
| Q3 2023 | 2023-09-30 | $2.7M | — | — |
Legend Biotech depreciation and amortization trends
Over the last five fiscal years, Legend Biotech's depreciation and amortization increased from $6.2M to $9.4M, a change of $3.2M. The latest reported quarter, Q2 2026, shows $11.7M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Legend Biotech source filings ↗